🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Status
Recruiting
Location
Liuzhou center for disease control and prevention
Start Date
2020-04-28
Trial ID
NCT04422366
This phase IV trial studies how well human papillomavirus (HPV) vaccine the...
Status
Terminated
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-08-01
Trial ID
NCT03051516
The purpose of this study is to determine the acceptability of HPV vaccinat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT04430907
Treatments Being Tested
This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Start Date
2019-06-26
Trial ID
NCT03998254
A randomized, observer-blind non-inferiority trial to evaluate alternative ...
Status
Unknown
Location
Ed Clarke
Start Date
2019-09-14
Trial ID
NCT03832049
The main purpose of this study was to evaluate the safety and reactogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-08-22
Trial ID
NCT05496231
Treatments Being Tested
Background: Diseases related to human papillomavirus (HPV) include warts, ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-02-04
Trial ID
NCT03519464
Treatments Being Tested
This phase II trial studies whether the nonavalent human papillomavirus vac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-06-23
Trial ID
NCT03036930
A total of 480 Chinese women aged 18-26 years old were enrolle，experimental...
Status
Completed
Location
Liucheng Center for Disease Control and Prevention
Start Date
2020-06-20
Trial ID
NCT04436133
Cervical cancer (CCU) is the fourth most common cancer in women worldwide. ...
Status
Completed
Location
Centre Hospitalier Universitaire de la Réunion
Start Date
2020-11-01
Trial ID
NCT04459221
Treatments Being Tested